Published in J Sports Med Phys Fitness on December 01, 2007
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Effect of the age at which smoking begins on frequency of smoking in adulthood. N Engl J Med (1991) 2.96
High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med (1998) 2.30
Ethnic differences in estrogen metabolism in healthy women. J Natl Cancer Inst (1996) 2.29
Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol (2006) 2.02
Re: Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst (1994) 1.74
Feasibility of a large prospective study in general practice: an Italian experience. Gruppo di Studio sulla Pressione Arteriosa nell'Anziano. Br Med J (Clin Res Ed) (1987) 1.65
Homocysteine, vitamin B12, and serum and erythrocyte folate in peritoneal dialysis and hemodialysis patients. Perit Dial Int (2000) 1.48
Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood (1998) 1.47
Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol (2001) 1.47
Risk factors for deep venous thrombosis of the upper extremities. Ann Intern Med (1997) 1.45
No association between genetic hemochromatosis and alpha1-antitrypsin deficiency. Hepatology (1996) 1.42
Lipid profile during rhGH therapy in pediatric renal transplant patients. Pediatr Transplant (2002) 1.40
Functional significance of different human CYP1A1 genotypes. Carcinogenesis (1994) 1.40
Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med (2000) 1.26
Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology (2001) 1.21
Risk of cerebral vein thrombosis and oral contraceptives. Lancet (1998) 1.18
Diet, metabolic polymorphisms and dna adducts: the EPIC-Italy cross-sectional study. Int J Cancer (2000) 1.16
Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev (2001) 1.14
11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer (2006) 1.14
Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis. Arterioscler Thromb Vasc Biol (1999) 1.12
Death from cardiovascular disease in Italy, 1972-1981: decline in mortality rates and possible causes. Int J Epidemiol (1988) 1.06
Distinct distribution of HPV types among cancer-free Afro-Caribbean women from Tobago. Biomarkers (2007) 1.01
Relationship between genotype and function of the human CYP1A1 gene. J Toxicol Environ Health (1993) 1.01
Recognition of oxidized DNA bases by sera of patients with inflammatory diseases. Free Radic Biol Med (1993) 1.00
MTHFR C677T polymorphism, GSTM1 deletion and male infertility: a possible suggestion of a gene-gene interaction? Biomarkers (2006) 0.99
Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis. Blood (2001) 0.98
Left ventricular structure and function in normotensive adolescents with a genetic predisposition to hypertension. Am Heart J (1986) 0.96
Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis. Dig Liver Dis (2003) 0.95
A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis (1993) 0.94
Feasibility of a long-term low-sodium diet in mild hypertension. J Hum Hypertens (1992) 0.93
Ecologic study of lung cancer risk factors in the U.S. and Japan, with special reference to smoking and diet. Jpn J Cancer Res (1992) 0.92
Interaction between smoking, GSTM1 deletion and colorectal cancer: results from the GSEC study. Biomarkers (2003) 0.92
In vitro quantification of anti-red blood cell antibody production in idiopathic autoimmune haemolytic anaemia: effect of mitogen and cytokine stimulation. Br J Haematol (2000) 0.91
Serum autoantibodies recognizing 5-hydroxymethyl-2'-deoxyuridine, an oxidized DNA base, as biomarkers of cancer risk in women. Cancer Epidemiol Biomarkers Prev (1998) 0.90
Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans. Carcinogenesis (2000) 0.90
Allele frequencies of polymorphisms of TNFA, IL-6, IL-10 and IFNG in an Italian Caucasian population. Eur J Immunogenet (2002) 0.88
Hemolytic uremic syndrome and cattle. Clin Nephrol (2003) 0.88
International collaborative study on genetic susceptibility to environmental carcinogens. Cancer Epidemiol Biomarkers Prev (1999) 0.87
Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers (1996) 0.87
Blood donors with 'medium' or 'minor' risk factors for human immunodeficiency virus infection: are they eligible for donation? Haematologica (2000) 0.87
Review and pooled analysis of studies on MTHFR C677T polymorphism and esophageal cancer. Toxicol Lett (2008) 0.87
The post-thrombotic syndrome in young women: retrospective evaluation of prognostic factors. Thromb Haemost (1998) 0.86
Prevalence of cancer-associated viral infections in healthy afro-Caribbean populations: a review of the literature. Cancer Invest (2008) 0.86
Prevalence and variability of orthostatic hypotension in the elderly. Results of the 'Italian study on blood pressure in the elderly (SPAA)'. The 'Gruppo di Studio Sulla Pressione Arteriosa nell'Anziano'. Eur Heart J (1992) 0.86
Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease. J Hepatol (2001) 0.85
Association of A313 G polymorphism (GSTP1*B) in the glutathione-S-transferase P1 gene with sporadic Parkinson's disease. Eur J Neurol (2007) 0.85
Monitoring human lymphocytic DNA-protein cross-links as biomarkers of biologically active doses of chromate. Environ Health Perspect (1996) 0.84
Iron status and HFE genotype in erythrocyte pyruvate kinase deficiency: study of Italian cases. Blood Cells Mol Dis (2001) 0.84
A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506). Arterioscler Thromb Vasc Biol (1997) 0.83
Free protein S deficiency is a risk factor for venous thrombosis. Thromb Haemost (1997) 0.83
Prevalence of Salmonella enterica and Listeria monocytogenes contamination in foods of animal origin in Italy. J Food Prot (2005) 0.83
International collaborative study on genetic susceptibility to environmental carcinogens (GSEC): an update. Int J Hyg Environ Health (2001) 0.83
Effects of a screening program for hypertension in a community. Acta Cardiol (1991) 0.82
Gene polymorphisms predicting high plasma levels of coagulation and fibrinolysis proteins. A study in centenarians. Arterioscler Thromb Vasc Biol (1997) 0.81
Preliminary report on a simple new assay for DNA-protein cross-links as a biomarker of exposures experienced by welders. J Toxicol Environ Health (1993) 0.81
Arm position as a source of error in blood pressure measurement. Clin Cardiol (1987) 0.81
Distribution of composite CYP1A1 genotypes in Africans, African-Americans and Caucasians. Hum Hered (1997) 0.80
Human metallothionein gene expression determined by quantitative reverse transcription-polymerase chain reaction as a biomarker of cadmium exposure. Cancer Epidemiol Biomarkers Prev (1996) 0.80
Long-term efficacy of screening for hypertension in a community. J Hypertens (1985) 0.80
Effect of vitamin levels on biomarkers of exposure and oxidative damage-the EXPAH study. Mutat Res (2008) 0.80
Vitamin supplement use and risk for oral and esophageal cancer. Nutr Cancer (1992) 0.80
Cyclosporine monitoring in stable, long-term, pediatric kidney transplant recipients: the value of C2 determination. Transplant Proc (2004) 0.80
DNA-protein crosslinks in peripheral lymphocytes of individuals exposed to hexavalent chromium compounds. Biomarkers (1996) 0.79
Occupational exposure to Cr(VI): comparison between chromium levels in lymphocytes, erythrocytes, and urine. Int Arch Occup Environ Health (1996) 0.79
Re: S. J. London et al., Lung cancer risk in African-Americans in relation to a race-specific CYP1A1 polymorphism. Cancer Res., 55: 6035-6037, 1995. Cancer Res (1996) 0.79
Role of blood pressure response to provocative tests in the prediction of hypertension in adolescents. Eur Heart J (1985) 0.78
Changes in self-reported family history of breast cancer with change in case-control status. Eur J Epidemiol (2001) 0.78
Left ventricular diastolic function in normotensive adolescents with different genetic risk of hypertension. Clin Cardiol (1990) 0.78
Meta-analysis of cancer incidence in children born after assisted reproductive technologies. Br J Cancer (2005) 0.78
Tumor incidence in heart transplant patients: report of the North Italy Transplant Program Registry. Transplant Proc (2001) 0.78
Metabolic gene polymorphisms and p53 mutations in healthy centenarians and younger controls. Biomarkers (2004) 0.78
[European multicenter cross-sectional study on exposure to low doses of benzene]. G Ital Med Lav Ergon (2003) 0.77
Occupational exposures to Cd, Ni, and Cr modulate titers of antioxidized DNA base autoantibodies. Environ Health Perspect (1994) 0.77
[Systemic and pulmonary vascular resistance in brain death]. Minerva Anestesiol (2000) 0.77
Reduced IL-6 levels among individuals in Hudson County, New Jersey, an area contaminated with chromium. Arch Environ Health (1996) 0.77
Genetic risk factors for superficial vein thrombosis. Thromb Haemost (1999) 0.77
Breast cancer--the optimal diet. Adv Exp Med Biol (1992) 0.76
Association of metabolic gene polymorphisms with alcohol consumption in controls. Biomarkers (2004) 0.76
Prevalence of symptoms generally attributed to hypertension or its treatment: study on blood pressure in elderly outpatients (SPAA). J Hypertens Suppl (1988) 0.76
Gene--environment interactions in the application of biomarkers of cancer susceptibility in epidemiology. IARC Sci Publ (1997) 0.76
Bone mineral density and body composition in ulcerative colitis: a six-year follow-up. Osteoporos Int (2001) 0.76
Lack of interaction between asbestos exposure and glutathione S-transferase M1 and T1 genotypes in lung carcinogenesis. Cancer Epidemiol Biomarkers Prev (2001) 0.76
Bone mineral density and body composition in patients with ulcerative colitis. Am J Gastroenterol (2000) 0.76
Re: "Validated questionnaire for the identification of previous personal or familial venous thromboembolism". Am J Epidemiol (1998) 0.75
Re: A. W. Hsing et al., Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res., 50: 6836-6840, 1990. Cancer Res (1991) 0.75
Deletion of parental GST genes as a possible susceptibility factor in the etiology of infant leukemia. Leuk Res (2000) 0.75
Family history, body-fat distribution, and the risk of breast cancer. N Engl J Med (1992) 0.75
Role of simian virus 40 in cancer incidence in solid organ transplant patients. Br J Cancer (2006) 0.75
[Accuracy of anamnestic data in the definition of the familial history of hypertension]. Cardiologia (1985) 0.75
Vitamin supplement use in a hospital-based population. Eur J Cancer Prev (1992) 0.75
[Behavior of blood pressure during exercise in adolescents at various risks of developing hypertension]. Cardiologia (1984) 0.75
[Association between arterial pressure and other cardiovascular risk factors in adolescence]. G Ital Cardiol (1985) 0.75
TNFalpha promoter polymorphisms in Italian patients with porphyria cutanea tarda. Dig Liver Dis (2003) 0.75
[Efficacy of screening for arterial hypertension in an adult population]. Cardiologia (1984) 0.75
[Therapy of arterial hypertension: benefits and risks]. Riv Inferm (1984) 0.75
[M-mode echocardiogram in adolescents genetically predisposed to the development of hypertension]. Cardiologia (1983) 0.75
[Index of left ventricular hypertrophy in adolescents genetically predisposed to the development of arterial hypertension]. G Ital Cardiol (1985) 0.75